Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-24 @ 9:59 PM
NCT ID:
NCT04359732
Eligibility Criteria:
Inclusion Criteria:
* biopsy-proven esophageal or junctional carcinomas (either adenocarcinoma (AC) or squamous cell carcinoma (SCC) for which an Ivor-Lewis transthoracic esophagectomy with supramesocolic and mediastinal lymphadenectomy is indicated;
* visible tumor on pre-treatment imaging;
* ≥ 18 years of age;
* signed informed consent.
Exclusion Criteria:
* \- incomplete preoperative imaging assessment;
* contraindications to neoadjuvant treatment;
* contraindications to preoperative imaging (such as pacemaker, allergy to contrast agents);
* inability to complete imaging examinations (i.e. severe claustrophobia);
* contraindication to surgery (comorbidities, distant metastatic disease (imaging confirmed));
* pregnant or lactating women
* severe hypersensitivity to gadobutrol or fludeoxyglucose F18.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04359732
Study Brief:
Protocol Section:
NCT04359732